The close monitoring of acute myeloid leukaemia (AML) patients in routine care includes an array of biochemical specimens, amongst these C-reactive protein (CRP) and plasma albumin (PA) that are performed repeatedly during the course of AML. Here, ALB is linked to acute myeloid leukemia.